Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PAOLA: NT 201 for platysma prominence
NCT05773053Phase 2Completed
- Sponsor
- Merz
- Start
- Mar 2023
- Primary completion
- Oct 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of incobotulinumtoxinA in platysma prominence, sponsored by Merz. Started Mar 2023; status: completed.
02
Drugs
incobotulinumtoxinA
03
Conditions
platysma prominence
Beyond the preview
Go deeper on NCT05773053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05773053.